Biodexa Pharmaceuticals (MTP) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free MTP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineExtend Life Expectancy Against Aggressive Brain Cancers - Nano-Cap Firm Biodexa's Investigational Drug Shows Potentialbenzinga.com - March 28 at 1:49 PMWhy Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today?investorplace.com - March 28 at 12:11 PMBiodex stock slides 7% amid data for two drug studiesmsn.com - February 23 at 8:57 PMWhy Is Brain Cancer Focused-Biodexa Pharmaceuticals Stock Trading Higher Today?msn.com - February 13 at 3:11 PMCrude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plungemsn.com - December 19 at 4:01 PMBiodexa Announces Pricing of $5.2 Million Underwritten Public Offeringtmcnet.com - December 19 at 9:37 AMBiodexa Pharmaceuticals PLC Announces Results Of Appeal Of Delisting Determinationbenzinga.com - July 8 at 9:54 AMBDRX Biodexa Pharmaceuticals Plcseekingalpha.com - April 25 at 8:04 PMBiodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants & Issue of Equityfinance.yahoo.com - April 4 at 3:25 PMWhy Is Midatech Pharma (BDRX) Stock Up 64% Today?investorplace.com - March 28 at 9:17 AMMidatech Pharma PLC Announces Private Placement Raising US $6.0 millionfinance.yahoo.com - February 9 at 3:29 PMBioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plcfinancialpost.com - January 23 at 9:28 AMMidatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Studyfinance.yahoo.com - January 12 at 7:34 AMBIOAF: Merger with Midatech Pharmafinance.yahoo.com - January 3 at 3:29 PMMidatech Pharma PLC Announces Proposed Acquisition of Bioasis Technologies Incfinance.yahoo.com - December 13 at 1:49 PMBioasis Technologies Inc. Announces Merger with Midatech Pharma plcfinance.yahoo.com - December 13 at 1:49 PMMTP Midatech Pharma plcseekingalpha.com - October 11 at 12:50 PMMidatech Pharma Will Need Extra Financing in 1Q 2023; Mulling Optionsmarketwatch.com - September 14 at 10:02 PMMidatech Pharma PLC Announces ADR Ratio Changefinance.yahoo.com - September 14 at 10:17 AMmarketbeat.com - September 14 at 9:53 AMMidatech Pharma PLC Newsthestreet.com - August 3 at 12:44 AMMidatech Pharma PLC Announces MTX110 Development for the Treatment of Gliomafinance.yahoo.com - June 21 at 4:04 AMMidatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022yahoo.com - June 10 at 3:47 AMMidatech Pharma: MTX110’s Path To Market Fast-Tracked In RGBMuk.investing.com - June 7 at 8:40 PMMidatech Pharma climbs on FDA’s Fast Track Designation for brain tumor candidateseekingalpha.com - June 1 at 10:13 AMMidatech's investigational glioblastoma treatment gets Fast Track statusfinance.yahoo.com - June 1 at 10:13 AMMidatech Pharma receives noncompliance notice from Nasdaqseekingalpha.com - April 14 at 12:11 PMMidatech Pharma PLC Announces Appointment of Nominated and Financial Adviserfinance.yahoo.com - March 8 at 9:37 AMMidatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effectivefinance.yahoo.com - December 13 at 8:08 AMMidatech Pharma Plc - ADR Shares Approach 52-Week Low - Market Movernasdaq.com - November 27 at 6:36 PMMidatech Pharma Reported H1 Revenue +157% to 430K STG; H1 Operating Loss -3.15M vs -17.42M YoYbenzinga.com - September 17 at 8:41 AMMidatech Pharma PLC American Depositary Shs (MTP)nasdaq.com - August 20 at 9:14 AM Get Biodexa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MTP and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> MTP Media Mentions By Week MTP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MTP News Sentiment▼0.000.32▲Average Medical News Sentiment MTP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MTP Articles This Week▼00▲MTP Articles Average Week Get Biodexa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MTP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VCNX News AIMD News FWBI News ATXI News XBIO News KZIA News SHPH News HOTH News ENVB News ADXS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MTP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
